Your browser doesn't support javascript.
loading
Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker.
Wang, Yuling; Ramachandran, Vijaya; Sui, Dawen; Xu, Kejing; Haydu, Lauren E; Fang, Shenying; McQuade, Jennifer L; Fisher, Sarah B; Lucci, Anthony; Keung, Emily Z; Wargo, Jennifer; Gershenwald, Jeffrey E; Ross, Merrick I; Lee, Jeffrey E.
Affiliation
  • Wang Y; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ramachandran V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sui D; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Xu K; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Fang S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Fisher SB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lucci A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wargo J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: jelee@mdanderson.org.
J Invest Dermatol ; 142(7): 2046-2049.e3, 2022 07.
Article in En | MEDLINE | ID: mdl-34952092
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Melanoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Invest Dermatol Year: 2022 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Melanoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Invest Dermatol Year: 2022 Document type: Article Affiliation country: United States